Vertebral Augmentation Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 4.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Vertebral Augmentation Market Analysis
The vertebral augmentation market is expected to register a CAGR of 4.2% during the forecast period.
- The COVID-19 pandemic has imposed a burden on healthcare systems and intensive care unit (ICU) capacity that has led to the suspension of several procedures, including spine fractures and vertebral surgeries. For instance, according to the research article published in the Geriatric Orthopaedic Surgery and Rehabilitation Journal in April 2022, there have been visible changes in the hospital admissions of patients with vertebral compression fractures (VCF) as compared to the pre-pandemic period.
- In addition, as per the same source, fewer people (38 people in the pandemic as compared to 134 people in the pre-pandemic period) went to the emergency room for VCF during the peak of the COVID-19 pandemic. However, with resumed surgical services and increased road and sports injuries among the population, the studied market is expected to gain traction during the forecast period.
- Factors such as the high prevalence of osteoporosis and injuries due to accidents and sports, the rising geriatric population, as well as technological advancements and ongoing research in the area, are expected to drive the market growth over the forecast period.
- The increasing number of osteoporosis cases among the population is the key factor driving the market growth. For instance, according to the 2022 data published by the International Osteoporosis Foundation, one in three women over 50 years and one in five men are likely to experience osteoporotic fractures in their lifetime. As per the same source, osteoporosis would be responsible for three million fractures resulting in USD 25.3 billion in costs per year by 2025. Thus, the expected increase in the number of fractures caused by osteoporosis is anticipated to fuel the demand for kyphoplasty/vertebroplasty procedures, hence propelling market growth.
- Similarly, the growing incidence of sports injuries and accident cases is contributing to a rise in the number of vertebral augmentation procedures globally, which is expected to drive the market over the study period. For instance, according to the data published by the United Kingdom Spinal Injury Association, in July 2021, approximately 2,500 people were injured or diagnosed with spinal cord injuries each year, with an estimated 50,000 people in the United Kingdom living with them.
- Also, as per an article published in PLOS One in June 2022, the five most dangerous sports that cause the most injuries in 2021 are basketball with 2,823 injury cases, American football with 1,719, soccer with 1,289, baseball with 347, and boxing with 247 injury cases. Thus, the high number of road accidents and sport injury cases among the population raises the risk of vertebral fractures, which fuels the demand for vertebroplasty or kyphoplasty procedures, propelling the market growth.
- Furthermore, the increasingly aging population is more prone to develop osteoporosis, raising the risk of vertebral compression fractures causing significant pain and inability to perform daily life activities. This, in turn, is expected to increase the need for surgical procedures to reduce pain and further collapse the vertebral body, thereby bolstering market growth. For instance, according to the World Health Organization (WHO) Ageing and Health report in October 2022, the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.
- Therefore, due to factors such as the high number of road and sports injuries, growing incidences of osteoporosis, the increasing geriatric population, and new product launches, the studied market is anticipated to grow over the forecast period. However, the high cost of surgeries is likely to hinder the market growth over the forecast period.
Vertebral Augmentation Market Trends
Kyphoplasty Segment Expects to Register a Significant CAGR Over the Forecast Period
- The kyphoplasty involves injecting a special cement into the vertebrae as well as making space for the procedure with a balloon-like device (balloon vertebroplasty). Kyphoplasty can restore the height of a damaged vertebra and possibly alleviate pain. The kyphoplasty devices segment is expected to witness significant growth in the vertebral augmentation market over the forecast period owing to the factors such as the increasing incidences of osteoporosis among the population and growing cases of cancer-damaged vertebrae or certain spinal fractures.
- The kyphoplasty procedure is preferred for treating fractured vertebrae with minimal incisions due to several benefits over vertebroplasty procedures, including short-term pain relief, improvement of the short- and long-term kyphotic angle, lower cement leakage rate, improvement in mobility and quality of life, and for increasing vertebral body height as well as reduced kyphosis.
- For instance, according to an article published in Frontiers in Surgery Journal in July 2022, it has been observed that kyphoplasty is more frequently used for the clinical treatment of osteoporotic vertebral compression fractures, spinal metastatic tumors, hemangiomas, myelomas, and vertebral nonunion.
- In addition, kyphoplasty may be a safe and effective treatment for ankylosing spondylitis patients who have thoracic or lumbar fractures with the intravertebral vacuum phenomenon. This procedure relieves pain, improves function, restores the anterior and middle height, and corrects the kyphotic angle of the fractured vertebra.
- Similarly, as per an article published in Frontiers in Surgery in February 2022, it has been observed that both percutaneous kyphoplasty (PKP) with or without posterior pedicle screw fixation (PPSF) can maintain the spinal sagittal balance and produce excellent clinical results. In addition, PKP demonstrated more substantial advantages in the early postoperative period as compared to PPSF+KP. Thus, the above studies showed that kyphoplasty is effective in treating vertebral fractures in patients, which is anticipated to fuel the segment growth over the forecast period.
- Furthermore, the rising product launches are also contributing to the market growth. For instance, in October 2021, IZI Medical Products, LLC launched Vertefix HV Cement, a unique solution that addresses the need for real-time flow visualization during cement injection for kyphoplasty procedures. Therefore, owing to the factors mentioned above, the studied market is anticipated to grow over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
- North America is anticipated to hold a significant share of the market over the forecast period due to the high demand for vertebral augmentation procedures owing to the high burden of osteoporosis and spine injuries. Also, the presence of robust healthcare infrastructure and the launch of new products in the area by the companies are further expected to have a significant impact on the market.
- According to the 2023 data published by the American Association of Neurological Surgeons, vertebral compression fractures (VCF) are the most common fracture in patients with osteoporosis, affecting about 750,000 people annually in the United States.
- In addition, an estimated 25% of all postmenopausal women are estimated to be affected by VCFs, annually in the United States, and the prevalence of VCF steadily rises with age, affecting 40% of women 80 and older. Also, according to the data published by the American Association of Neurological Surgeons in June 2021, it has been observed that more than 450,000 people in the United States were living with spinal cord injury (SCI) in 2021.
- Additionally, as per the 2022 statistics published by Osteoporosis Canada, about 2.3 million Canadians are living with osteoporosis, and 80% of all fractures in people aged 50 years and above are caused by osteoporosis. Furthermore, according to the 2022 statistics published by United Nations Population Fund, about 19% and 17% of the population was aged 65 years and above in 2022 in Canada and the United States, respectively. Thus, a high percentage of the geriatric population is likely to develop osteoporosis which in turn raises the risk of vertebral fractures. This is anticipated to fuel the demand for augmentation procedures, hence propelling the market growth.
- Moreover, the rising product approvals in the region increase the availability of technologically advanced novel products in the market, which is also expected to fuel market growth. For instance, in April 2021, Agnovos Healthcare LLC received FDA approval for an IDE clinical trial to assess its AGN1 local osteo-enhancement procedure (LOEP) small-volume (SV) kit in patients with vertebral compression fractures (VCFs).
- The device is intended to treat stable but painful VCFs through a minimally invasive procedure. Therefore, owing to the aforementioned factors, such as the high burden of vertebral fractures and osteoporosis among the population, increasing product launches, and the growing aging population, the studied market is anticipated to grow over the forecast period.
Vertebral Augmentation Industry Overview
The vertebral augmentation market is highly consolidated. Some of the key companies in the market are Medtronic, Johnson & Johnson, Stryker Corporation, Globus Medical, Inc., Merit Medical Systems, Inc., BMK Global Medical Company, IZI Medical Products, and Zavation, among others.
Vertebral Augmentation Market Leaders
Johnson & Johnson
Stryker Corporation
Globus Medical, Inc
Merit Medical Systems, Inc
Medtronic PLC
*Disclaimer: Major Players sorted in no particular order
Vertebral Augmentation Market News
- September 2022: Stryker received United States FDA approval for its OptaBlate bone tumor ablation system (OptaBlate). This launch assists the company to expands its core competencies in vertebral augmentation and radiofrequency ablation and completes its portfolio of treatment options for metastatic vertebral body fractures.
- April 2022: Nanox received FDA approval for HealthOST Device, an AI software monitoring vertebral compression fractures and low bone density frequently associated with osteoporosis.
Vertebral Augmentation Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Prevalence of Osteoporosis and Injuries due to Accidents and Sports
4.2.2 Rising Geriatric Population
4.2.3 Technological Advancements and Ongoing Research in the Area
4.3 Market Restraints
4.3.1 High Cost of the Surgeries
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product
5.1.1 Vertebroplastic Device
5.1.2 Kyphoplastic Device
5.2 By End-User
5.2.1 Hospitals
5.2.2 Ambulatory Surgery Centers
5.2.3 Other End-Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic Plc
6.1.2 Johnson & Johnson
6.1.3 Alphatec Spine, Inc.
6.1.4 Stryker Corporation
6.1.5 Globus Medical, Inc.
6.1.6 Merit Medical Systems, Inc.
6.1.7 BIOPSYBELL Srl
6.1.8 IZI Medical Products, LLC
6.1.9 RONTIS
6.1.10 Zavation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Vertebral Augmentation Industry Segmentation
As per the scope of the report, vertebral augmentation is a minimally invasive, image-guided surgical method. It is used for curing vertebral compression fracture and other spinal injuries, which leads to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping.
The vertebral augmentation market is segmented by product (vertebroplastic device and kyphoplastic device), end user (hospitals, ambulatory surgery centers, and others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions.
The report offers the value (in USD million) for the above segments.
| By Product | |
| Vertebroplastic Device | |
| Kyphoplastic Device |
| By End-User | |
| Hospitals | |
| Ambulatory Surgery Centers | |
| Other End-Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Vertebral Augmentation Market Research FAQs
What is the current Vertebral Augmentation Market size?
The Vertebral Augmentation Market is projected to register a CAGR of 4.20% during the forecast period (2024-2029)
Who are the key players in Vertebral Augmentation Market?
Johnson & Johnson, Stryker Corporation, Globus Medical, Inc, Merit Medical Systems, Inc and Medtronic PLC are the major companies operating in the Vertebral Augmentation Market.
Which is the fastest growing region in Vertebral Augmentation Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Vertebral Augmentation Market?
In 2024, the North America accounts for the largest market share in Vertebral Augmentation Market.
What years does this Vertebral Augmentation Market cover?
The report covers the Vertebral Augmentation Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Vertebral Augmentation Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Vertebral Augmentation Industry Report
Statistics for the 2024 Vertebral Augmentation market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Vertebral Augmentation analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
